^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

arzoxifene (LY353381)

i
Other names: LY353381
Associations
Company:
Eli Lilly
Drug class:
Selective estrogen receptor modulator
Associations
9ms
Estrogen Promotes Endometrial Cancer Development by Modulating ZNF626, SLK, and RFWD3 Gene Expression and Inducing Immune Inflammatory Changes. (PubMed, Biomedicines)
Ishikawa cells and ECC-1 cells were stimulated with estradiol (E2) or the selective estrogen receptor modulator Arzoxifene, and qPCR was performed to measure gene expression changes... Estrogen promotes cell proliferation and inhibits apoptosis by upregulating ZNF626 and SLK, while downregulating RFWD3. Furthermore, estrogen induces a shift in the tumor microenvironment, characterized by a reduction in memory CD4+ T cells and a transition from M1 to M2 macrophage phenotypes, thus facilitating the onset and progression of EC.
Journal
|
CD4 (CD4 Molecule)
|
arzoxifene (LY353381)